Perkins Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vericel Corp
VCEL
|
+$1.17M |
| 2 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$1.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.02M |
| 4 |
ATHX
Athersys, Inc. Common Stock
ATHX
|
+$556K |
| 5 |
Veracyte
VCYT
|
+$506K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CryoPort
CYRX
|
+$1.36M |
| 2 |
JetBlue
JBLU
|
+$1.05M |
| 3 |
AtriCure
ATRC
|
+$959K |
| 4 |
NCR Voyix
VYX
|
+$854K |
| 5 |
SNAK
Inventure Foods, Inc.
SNAK
|
+$705K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.84% |
| 2 | Technology | 9.27% |
| 3 | Industrials | 8.69% |
| 4 | Communication Services | 3.79% |
| 5 | Financials | 2.84% |
Similar funds
Perkins Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Perkins Capital Management held 118 positions worth $95.4M, up 5.9% from $90.2M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Perkins Capital Management withdrew a net $3.93M in Q3 2017, closing 16 positions and reducing 46 holdings. Its most notable exit was JetBlue, an estimated $1.05M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in Bristol-Myers Squibb worth $1.12M.
- Perkins Capital Management's largest Q3 2017 buy was Bristol-Myers Squibb: 17,525 shares worth $1.12M.
- Perkins Capital Management added most to Vericel Corp in Q3 2017, an estimated $1.17M increase.
- Perkins Capital Management's biggest Q3 2017 reduction was CryoPort, cutting an estimated $1.36M.
- Perkins Capital Management fully exited JetBlue in Q3 2017, selling an estimated $1.05M.
- Perkins Capital Management's ten largest holdings make up 39% of its $95.4M portfolio in Q3 2017.
- Perkins Capital Management opened 12 new positions and closed 16 in Q3 2017.
- Perkins Capital Management's portfolio value rose 5.9% quarter-over-quarter to $95.4M.
Based on Perkins Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.